• About us
  • People
  • Projects
  • Open Positions
  • Publications
  • Seminars

Blaeschke F, Ortner E, Stenger D, Mahdawi J, Apfelbeck A, Habjan N, Weißer T, Kaeuferle T, Willier S, Kobold S, Feuchtinger T. (2025) Design and Evaluation of TIM-3-CD28 Checkpoint Fusion Proteins to Improve Anti-CD19 CAR T-Cell Function.

by TUMbrandherde | Jun 4, 2025

Lorenzini T, Cadilha BL, Obeck H, Benmebarek MR, Märkl F, Michaelides S, Strzalkowski T, Briukhovetska D, Müller PJ, Nandi S, Winter P, Majed L, Grünmeier R, Seifert M, Rausch S, Feuchtinger T, Endres S, Kobold S. (2025) Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapy.

by TUMbrandherde | Jun 4, 2025

Kobold, S. (2025) RORing CAR T Cells in Solid and Hematologic Cancers: Same but Different

by TUMbrandherde | Jun 4, 2025

Mestermann, K; Garitano-Trojaola, A; Hudecek, M. (2025) Accelerating CAR-T Cell Therapies with Small-Molecule Inhibitors

by TUMbrandherde | Jun 4, 2025

Schütz, B; Krause, FF; Taudte, RV; Zaiss, MM; Luu, M; Visekruna, A. (2025) Modulation of Host Immunity by Microbiome-Derived Indole-3-Propionic Acid and Other Bacterial Metabolites

by TUMbrandherde | Jun 4, 2025

« Older Entries

Recent Posts

  • Joint publication by Matthias Feige and Kathrin Schumann: Human interleukin-12α and EBI3 are cytokines with anti-inflammatory functions
  • Joint publication by Ulrike Protzer and Matthias Feige: Modeling of the human interleukin 12:receptor complex allows to engineer attenuated cytokine variants
  • New publication of Marion Subklewe in Cancer Immunology Research: “Influence of adipose tissue distribution, sarcopenia and nutritional status on clinical outcomes after CD19 CAR T-cell therapy”
  • New publication by Veit Buchholz in nature
  • New publication on cytotoxic T cells in SARS-CoV2 infection

Recent Comments

  1. A WordPress Commenter on New publication on cytotoxic T cells in SARS-CoV2 infection
  • Contact
  • About Letsimmun
  • News
  • Open Positions
  • Follow
  • Follow
  • Privacy
  • Imprint